Data as of 11:54am ET
| -0.062 / -3.10%|
The 1 analysts offering 12-month price forecasts for Oragenics Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +261.20% increase from the last price of 1.94.
The current consensus among 1 polled investment analysts is to Buy stock in Oragenics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.